EVAX

About Evaxion A/S American Depositary Share (EVAX) Stock

Evaxion A/S American Depositary Share (EVAX) closed the 2026-09-16 session at $3.03, down 0.33% versus the previous close (-0.01). The stock opened at $3.03 and traded between $3.00 and $3.24 during that session. Session trading volume was 74K shares. The volume-weighted average price (VWAP) is $3.11.

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Evaxion A/S American Depositary Share has a market capitalization of $27.4 million. EVAX is listed on the XNAS exchange. The company employs approximately 46 people. The recorded listing date is 2021-02-05.

On this page you can find market EVAX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.